Quantum Helium Limited QHE
LSE · Birleşik Krallık · Enerji Mineralleri
GBp 1,57-0,08 (-%5,09)
Piyasa açık· · GBp · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa açık· · GBp · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Sunda Energy PLC (AIM:SNDA, FRA:GHA0) has raised £5.25 million to fund completion of its New Zealand acquisition. It's also launching a retail offer for a further £525,000. Meridian Mining Plc (LSE:MNO, TSX:MNO, OTCQX:MRRDF) has delivered a net present value of $2.09 billion for its Cabaçal project in Brazil. The CEO says the economics could make it the next major near-term gold-copper mine. Quantum Helium Ltd (AIM:QHE) is targeting Q4 2026 for a larger fracture stimulation programme at Sagebrush-1 in Colorado. It's also taking a 9% stake in Herencia Resources. Light Science Technologies Holdi
Iofina PLC (AIM:IOF, OTC:IOFNF) jumped over 4% in early trading after boosting output at its IO#11 plant with a new brine source. It said the extra supply should lift crystalline iodine production there by 50%. Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF, FRA:TMU) says final preliminary drilling results back up the scale of its Discovery Zone at Mushima North in Zambia. It's now heading towards a maiden resource estimate this year. Quantum Helium Ltd (AIM:QHE) has mapped out five new drilling targets in Colorado after strong helium and oil results. It's now planning a bigger stimulation programm
CelLBxHealth PLC (AIM:CLBX, FRA:DWV) jumped 6% after a new study showed its Parsortix system can spot cancer drug targets in blood samples. It even caught targets that rival tests would've missed completely. Coiled Therapeutics (AIM:COIL, OTCQB:COTXF) has dosed its first US patient with a reworked version of its cancer drug AO-252. The new capsule fixes an absorption problem and no safety issues have shown up yet. Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) got fast-tracked examination from the US patent office for its longevity gene variant. It's also had a second patent publishe
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.